The report highlights Takeda's commitment to purpose-led sustainability, focusing on Patient, People, and Planet. Key achievements include achieving carbon neutrality across the value chain in FY2019, establishing a new carbon neutrality strategy, expanding R&D pipelines and investments, and strengthening health care systems. The report also discusses the company's response to the COVID-19 pandemic, including their involvement in cross-industry collaborations and the development of potential treatments.
Issuing Company Takeda Pharmaceutical Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 8.82 MB
No. of Pages 53 pages
Reporting periodApril 1, 2019 to March 31, 2020
Report EditionUnknown
Assurance Provider KPMG AZSA Sustainability Co., Ltd.
Reporting Standards GRI; UNSDG; SASB
Materiality Assessmenttrue